Anmelden/Registrieren
Erscheinungsjahr:
 
Zurück zur geteilten Ansicht
Hyman B. Muss

Veröffentlichungen von Hyman B. Muss zu Muss, Hyman B. ->
weitere Veröffentlichungen von Hyman B. Muss:
Endocrine therapy for advanced breast cancer: A review (1992)
Fatal esorubicin-induced cardiomyopathy: report of a case and review of the literature (1988)
Pharmacokinetics of vindesine bolus and infusion (1984)
Detection of brain metastasis at diagnosis of small cell carcinoma of the lung (1984)
Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer (1985)
Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (A phase II trial of the gynecologic oncology group) (1987)
Megestrol acetate in breast cancer — A panel discussion (1989)
Combination high-dose etoposide and vincristine infusion (1990)
Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix (1992)
Tamoxifen as initial endocrine therapy for metastatic breast cancer: Long term follow-up of two Piedmont Oncology Association (POA) trials (1997)
Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected cases (1990)
Recombinant gamma interferon in advanced breast cancer: A phase II trial (1986)
Phase I study of vincristine and escalating doses of etoposide (1989)
A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer (1991)
Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association (1994)
Veröffentlichungen zu Muss, Hyman B.
Zurück zur geteilten Ansicht
Verfasser Titel Jahr absteigend sortierenaufsteigend sortieren
zeige Details
1
Muss, Hyman B. Endocrine therapy for advanced breast cancer: A review
in: Breast cancer research and treatment , ISSN 1573-7217, Vol. 21 (1. 1992), p. 15-26
Zugang: zum Volltext
ähnliche Vorschläge
1992
zeige Details
2
Diehl, Louis F., Banks, Alan, ... Fatal esorubicin-induced cardiomyopathy: report of a case and review of the literature
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 21 (4. 1988), p. 347-350
Zugang: zum Volltext
ähnliche Vorschläge
1988
zeige Details
3
Jackson, Don V., Sethi, V. Sagar, ... Pharmacokinetics of vindesine bolus and infusion
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 13 (2. 1984), p. 114-119
Zugang: zum Volltext
ähnliche Vorschläge
1984
zeige Details
4
Cruz, Julia M., Jackson, Don V., ... Detection of brain metastasis at diagnosis of small cell carcinoma of the lung
in: Journal of neuro-oncology , ISSN 1573-7373, Vol. 2 (1. 1984), p. 67-71
Zugang: zum Volltext
ähnliche Vorschläge
1984
zeige Details
5
Kute, Timothy E., Muss, Hyman B., ... Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer
in: Breast cancer research and treatment , ISSN 1573-7217, Vol. 6 (2. 1985), p. 113-121
Zugang: zum Volltext
ähnliche Vorschläge
1985
zeige Details
6
Muss, Hyman B., Bundy, Brian N., ... Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (A phase II trial of the gynecologic oncology group)
in: Investigational new drugs , ISSN 1573-0646, Vol. 5 (2. 1987), p. 199-202
Zugang: zum Volltext
ähnliche Vorschläge
1987
zeige Details
7
McGuire, William L., Johnson, Patricia A., ... Megestrol acetate in breast cancer — A panel discussion
in: Breast cancer research and treatment , ISSN 1573-7217, Vol. 14 (1. 1989), p. 33-38
Zugang: zum Volltext
ähnliche Vorschläge
1989
zeige Details
8
Jackson, Don V., Cruz, Julia M., ... Combination high-dose etoposide and vincristine infusion
in: Investigational new drugs , ISSN 1573-0646, Vol. 8 (1. 1990), p. S59
Zugang: zum Volltext
ähnliche Vorschläge
1990
zeige Details
9
Muss, Hyman B., Blessing, John A., ... Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix
in: Investigational new drugs , ISSN 1573-0646, Vol. 10 (1. 1992), p. 25-26
Zugang: zum Volltext
ähnliche Vorschläge
1992
zeige Details
10
Kuss, Jana T., Muss, Hyman B., ... Tamoxifen as initial endocrine therapy for metastatic breast cancer: Long term follow-up of two Piedmont Oncology Association (POA) trials
in: Breast cancer research and treatment , ISSN 1573-7217, Vol. 42 (3. 1997), p. 265-274
Zugang: zum Volltext
ähnliche Vorschläge
1997
zeige Details
11
Ringenberg, Q. Scott, Propert, Kathleen J., ... Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected cases
in: Investigational new drugs , ISSN 1573-0646, Vol. 8 (2. 1990), p. 221-226
Zugang: zum Volltext
ähnliche Vorschläge
1990
zeige Details
12
Muss, Hyman B., Caponera, Mary, ... Recombinant gamma interferon in advanced breast cancer: A phase II trial
in: Investigational new drugs , ISSN 1573-0646, Vol. 4 (4. 1986), p. 377-381
Zugang: zum Volltext
ähnliche Vorschläge
1986
zeige Details
13
Jackson, Don V., Cruz, Julia M., ... Phase I study of vincristine and escalating doses of etoposide
in: Investigational new drugs , ISSN 1573-0646, Vol. 7 (2/3. 1989), p. 203-207
Zugang: zum Volltext
ähnliche Vorschläge
1989
zeige Details
14
Muss, Hyman B., Cooper, M. Robert, ... A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer
in: Breast cancer research and treatment , ISSN 1573-7217, Vol. 19 (2. 1991), p. 77-84
Zugang: zum Volltext
ähnliche Vorschläge
1991
zeige Details
15
Thomas, Gary W., Muss, Hyman B., ... Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 35 (2. 1994), p. 165-168
Zugang: zum Volltext
ähnliche Vorschläge
1994
zeige Details
16
Powell, Bayard L., Muss, Hyman B., ... Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 19 (3. 1987), p. 250-252
Zugang: zum Volltext
ähnliche Vorschläge
1987
zeige Details
17
Jackson, Don V, Pope, Ellen K, ... Improved tolerance of vincristine by glutamic acid
in: Journal of neuro-oncology , ISSN 1573-7373, Vol. 2 (3. 1984), p. 219-222
Zugang: zum Volltext
ähnliche Vorschläge
1984
zeige Details
18
Muss, Hyman B., Spell, Nancy, ... A phase II trial of peg-L-asparaginase in the treatment of non-hodgkins lymphoma
in: Investigational new drugs , ISSN 1573-0646, Vol. 8 (1. 1990), p. 125-130
Zugang: zum Volltext
ähnliche Vorschläge
1990
zeige Details
19
Jackson, Don V., Muss, Hyman B., ... CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 11 (3. 1983), p. 191-195
Zugang: zum Volltext
ähnliche Vorschläge
1983
zeige Details
20
Shipp, Sharon K., Muss, Hyman B., ... Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF)
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 11 (2. 1983), p. 130-133
Zugang: zum Volltext
ähnliche Vorschläge
1983